We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+6.34%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.21B
AUM Growth
+$52.5M
Cap. Flow
-$6.28M
Cap. Flow %
-0.52%
Top 10 Hldgs %
32.93%
Holding
265
New
7
Increased
40
Reduced
96
Closed
5

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.56M
2
PYPL icon
PayPal
PYPL
+$4.07M
3
META icon
Meta Platforms (Facebook)
META
+$3.04M
4
TMO icon
Thermo Fisher Scientific
TMO
+$2.87M
5
MSFT icon
Microsoft
MSFT
+$1.59M

Sector Composition

Rank Sector Weight
1 Technology 20.56%
2 Healthcare 18.49%
3 Financials 14.36%
4 Industrials 12.36%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
201
Aon
AON
$75.4B
$253K 0.02%
1,100
CRWD icon
202
CrowdStrike
CRWD
$228B
$252K 0.02%
5,532
CHD icon
203
Church & Dwight Co
CHD
$24.4B
$243K 0.02%
2,774
BKNG icon
204
Booking.com
BKNG
$158B
$233K 0.02%
2,500
MCHP icon
205
Microchip Technology
MCHP
$45.3B
$232K 0.02%
2,994
-130
-4% -$9.7K
D icon
206
Dominion Energy
D
$58.8B
$225K 0.02%
2,960
-430
-13% -$31.2K
PBCT
207
DELISTED
People's United Financial Inc
PBCT
$225K 0.02%
12,595
LLY icon
208
Eli Lilly
LLY
$1.08T
$224K 0.02%
1,200
WTM icon
209
White Mountains Insurance
WTM
$5.1B
$223K 0.02%
200
RPM icon
210
RPM International
RPM
$14.6B
$222K 0.02%
2,416
MER.PRK
211
Bank of America Income Capital Obligation Notes due December 15 2066
MER.PRK
$1.06B
$213K 0.02%
8,000
CE icon
212
Celanese
CE
$4.82B
$210K 0.02%
+1,400
New +$192K
ADM icon
213
Archer Daniels Midland
ADM
$38.1B
$205K 0.02%
3,600
-500
-12% -$27.4K
HWC icon
214
Hancock Whitney
HWC
$6.23B
$204K 0.02%
+4,850
New +$191K
WBA
215
DELISTED
Walgreens Boots Alliance
WBA
$200K 0.02%
+3,644
New +$180K
VTRS icon
216
Viatris
VTRS
$18.7B
$160K 0.01%
11,404
-2,317
-17% -$37.8K
PAA icon
217
Plains All American Pipeline
PAA
$16.3B
$146K 0.01%
16,000
WHWK
218
Whitehawk Therapeutics
WHWK
$262M
$129K 0.01%
6,667
NRT
219
North European Oil Royalty Trust
NRT
$84.6M
$125K 0.01%
27,999
PTPI
220
DELISTED
Petros Pharmaceuticals
PTPI
$82K 0.01%
88
MRKR icon
221
Marker Therapeutics
MRKR
$18.5M
$67K 0.01%
3,010
XCUR icon
222
Exicure
XCUR
$8.73M
$36K ﹤0.01%
111
MTNB icon
223
Matinas BioPharma
MTNB
$1.67M
$18K ﹤0.01%
350
ACAD icon
224
Acadia Pharmaceuticals
ACAD
$5.01B
-15,000
Closed -$802K
MFC icon
225
Manulife Financial
MFC
$73.5B
-10,660
Closed -$190K

Similar funds

Neville Rodie & Shaw's Q1 2021 Portfolio in Review

As of Q1 2021, Neville Rodie & Shaw held 265 positions worth $1.21B, up 4.5% from $1.15B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 4.5%. Neville Rodie & Shaw opened 7 new positions and exited 5, leaving the 265-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q1 2021 buy was ON Semiconductor: 214,450 shares worth $8.92M.
  • Neville Rodie & Shaw added most to Deere & Co in Q1 2021, an estimated $2.69M increase.
  • Neville Rodie & Shaw's biggest Q1 2021 reduction was Apple, cutting an estimated $4.56M.
  • Neville Rodie & Shaw fully exited Acadia Pharmaceuticals in Q1 2021, selling an estimated $802K.
  • Neville Rodie & Shaw's ten largest holdings make up 33% of its $1.21B portfolio in Q1 2021.
  • Neville Rodie & Shaw opened 7 new positions and closed 5 in Q1 2021.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $1.21B.

Based on Neville Rodie & Shaw's 13F filing for Q1 2021, filed 8 Apr 2021.